| SINO BIOPHARMACEUTICAL |
| China |
| Gesundheit |
| KYG8167W1380 / A0CBDJ |
| SMZ1 (Frankfurt) |
| FRA:SMZ1, ETR:SMZ1, SMZ1:GR |
| - |
| https://www.sinobiopharm... |
|
Sino Biopharmaceutical Ltd. is a diversified biopharmaceutical enterprise specializing in the research, development, manufacturing, and commercialization of a wide array of pharmaceuticals. The company's primary focus lies in four major categories: m..
>Volltext.. |
| 10782.09 Mio. EUR |
| 11384.09 Mio. EUR |
| 3782.85 Mio. EUR |
| 951.71 Mio. EUR |
| 273.72 Mio. EUR |
| 0.02 EUR |
| 1963.21 Mio. EUR |
| 902.19 Mio. EUR |
| - |
| 0.89 |
| -3.03% |
| 13.19% |
| 0.01 EUR |
| 1.62% |
| 1.84% |
| 29.08.25 - 0.005522€ 16.06.25 - 0.0044176€ >weitere anzeigen... |
| - |
| SINO BIOPHARMACEUTICAL, SINO BIOPHARMA, SINO BIOPHARM, SINO BIO |
| 29.04.26 |
|